
Cost-effectiveness of anti-SARS-CoV-2 antibody diagnostic tests in Brazil
2022; Public Library of Science; Volume: 17; Issue: 2 Linguagem: Inglês
10.1371/journal.pone.0264159
ISSN1932-6203
AutoresTália Santana Machado de Assis, Mariana Lourenço Freire, Janaína de Pina Carvalho, Ana Rabello, Gláucia Cota,
Tópico(s)Biosensors and Analytical Detection
ResumoAlthough serologic tests for COVID-19 diagnosis are rarely indicated nowadays, they remain commercially available and widely used in Brazil. The objective of this study was to evaluate the cost-effectiveness of anti-SARS-CoV-2antibody diagnostic tests for COVID-19 in Brazil.
Referência(s)